In the battle against COVID-19, various companies have been working on developing tests with dramatically reduced turnaround times, while others are working frenetically on developing potential vaccines. When it comes to his top stock for the fight against COVID-19, however, the author of today’s article has a “slightly different” pick: “a classic picks-and-shovel play…which makes software that lets drug companies simulate tests of their products in the virtual world before undergoing human or animal testing. This is a big cost saver for drug companies.” For more, CLICK HERE.
A “Slightly Different” COVID-19 Vaccine Play
- by Bob Mitchell